Historical review: Negative efficacy and the constitutive activity of G-protein-coupled receptors

Trends in Pharmacological Sciences

Volumn 26, Issue 12, 2005, Pages 618-624

  Costa, Tommaso ^a   Cotecchia, Susanna ^b  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; G PROTEIN COUPLED RECEPTOR;

DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFICACY; HUMAN; MEDICAL LITERATURE; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW;

ANIMALS; HUMANS; LIGANDS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 27744451411     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2005.10.009     Document Type: Review

References (90)

1. R.J. Lefkowitz Historical review: A brief history and personal retrospective of seven-transmembrane receptors Trends Pharmacol. Sci. 25 2004 413 422
2. T. Kenakin Principles: Receptor theory in pharmacology Trends Pharmacol. Sci. 25 2004 186 192
3. T. Kenakin Efficacy as a vector: the relative prevalence and paucity of inverse agonism Mol. Pharmacol. 65 2004 2 11
4. C. Braestrup Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors Proc. Natl. Acad. Sci. U. S. A. 77 1980 2288 2292
5. C. Braestrup Interaction of convulsive ligands with benzodiazepine receptors Science 216 1982 1241 1243
6. R.L. Macdonald, and R.W. Olsen GABAA receptor channels Annu. Rev. Neurosci. 17 1994 569 602
7. E. Sigel, and A. Buhr The benzodiazepine binding site of GABAA receptors Trends Pharmacol. Sci. 18 1997 425 429
8. E.A. Barnard International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function Pharmacol. Rev. 50 1998 291 313
9. G. Weber Energetics of ligand binding to proteins Adv. Protein Chem. 29 1975 1 83
10. J. Wyman Allosteric linkage J. Am. Chem. Soc. 89 1967 2202 2218
11. J. Wyman, and S.J. Gill Binding and Linkage. Functional Chemistry of Biological Macromolecules 1990 University Science Books
12. H.O. Onaran A look at receptor efficacy. From the signaling network of the cell to the intramolecular motion of the receptor T.P. Kenakin J.A. Angus The Pharmacology of Functional, Biochemical, and Recombinant Systems 2000 Springer 217 280
13. H.O. Onaran, and T. Costa Intramolecular dynamics and ligand-induced conformational changes: a stochastic model of receptor action A. Christopoulos Biomedical Applications of Computer Modeling 2001 CRC Press 109 134
14. E. Di Cera Site-specific thermodynamics: understanding cooperativity in molecular recognition Chem. Rev. 98 1998 1563 1592
15. R.P. Stephenson A modification of receptor theory Br. J. Pharmacol. 11 1956 379 393
16. R.F. Furchgott The use of b-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes N.J. Harper A.B. Simmonds Advances in Drug Research 1966 Academic Press 21 55
17. J.W. Black, and P. Leff Operational models of pharmacological agonism Proc. R. Soc. Lond. B. Biol. Sci. 220 1983 141 162
18. D. Colquhoun The relationship between classical and cooperative models for drug action H.P. Rang Drug Receptors 1973 University Park Press 149 182
19. D. Colquhoun Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors Br. J. Pharmacol. 125 1998 924 947
20. J. Del Castillo, and B. Katz Interaction at end-plate receptors between different choline derivatives Proc. R. Soc. Lond. B. Biol. Sci. 146 1957 369 381
21. M. Rodbell The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. IV. Effects of guanylnucleotides on binding of 125I-glucagon J. Biol. Chem. 246 1971 1872 1876
22. A. De Lean A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor J. Biol. Chem. 255 1980 7108 7117
23. R.S. Kent A quantitative analysis of beta-adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modeling of ligand binding data Mol. Pharmacol. 17 1980 14 23
24. R.A. Cerione The mammalian beta 2-adrenergic receptor: reconstitution of functional interactions between pure receptor and pure stimulatory nucleotide binding protein of the adenylate cyclase system Biochemistry 23 1984 4519 4525
25. S.E. Pedersen, and E.M. Ross Functional activation of beta-adrenergic receptors by thiols in the presence or absence of agonists J. Biol. Chem. 260 1985 14150 14157
26. T. Costa, and A. Herz Antagonists with negative intrinsic activity at delta opioid receptors coupled to GTP-binding proteins Proc. Natl. Acad. Sci. U. S. A. 86 1989 7321 7325
27. T. Costa Spontaneous association between opioid receptors and GTP-binding regulatory proteins in native membranes: specific regulation by antagonists and sodium ions Mol. Pharmacol. 37 1990 383 394
28. G. Hilf, and K.H. Jakobs Agonist-independent inhibition of G protein activation by muscarinic acetylcholine receptor antagonists in cardiac membranes Eur. J. Pharmacol. 225 1992 245 252
29. K. Gotze, and K.H. Jakobs Unoccupied beta-adrenoceptor-induced adenylyl cyclase stimulation in turkey erythrocyte membranes Eur. J. Pharmacol. 268 1994 151 158
30. R. Hanf Agonist-independent effects of muscarinic antagonists on Ca2+ and K+ currents in frog and rat cardiac cells J. Physiol. 461 1993 743 765
31. S. Cotecchia Regions of the alpha 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function Proc. Natl. Acad. Sci. U. S. A. 87 1990 2896 2900
32. M.A. Kjelsberg Constitutive activation of the alpha 1B-adrenergic receptor by all amino acid substitutions at a single site. Evidence for a region which constrains receptor activation J. Biol. Chem. 267 1992 1430 1433
33. P. Samama A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model J. Biol. Chem. 268 1993 4625 4636
34. Q. Ren Constitutively active mutants of the alpha 2-adrenergic receptor J. Biol. Chem. 268 1993 16483 16487
35. L.F. Allen G-protein-coupled receptor genes as protooncogenes: constitutively activating mutation of the alpha 1B-adrenergic receptor enhances mitogenesis and tumorigenicity Proc. Natl. Acad. Sci. U. S. A. 88 1991 11354 11358
36. J. Parma Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas Nature 365 1993 649 651
37. A. Shenker A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty Nature 365 1993 652 654
38. T. Costa Drug efficacy at guanine nucleotide-binding regulatory protein-linked receptors: thermodynamic interpretation of negative antagonism and of receptor activity in the absence of ligand Mol. Pharmacol. 41 1992 549 560
39. R.J. Lefkowitz Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins Trends Pharmacol. Sci. 14 1993 303 307
40. J.M. Weiss The cubic ternary complex receptor-occupancy model. III. resurrecting efficacy J. Theor. Biol. 181 1996 381 397
41. M. Bouaboula A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions J. Biol. Chem. 272 1997 22330 22339
42. F. Monczor Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. Experimental support for the cubic ternary complex model Mol. Pharmacol. 64 2003 512 520
43. R.A. Bakker Constitutively active Gq/11-coupled receptors enable signaling by co-expressed G(i/o)-coupled receptors J. Biol. Chem. 279 2004 5152 5161
44. W. Schutz, and M. Freissmuth Reverse intrinsic activity of antagonists on G protein-coupled receptors Trends Pharmacol. Sci. 13 1992 376 380
45. R. Leurs Agonist-independent regulation of constitutively active G-protein-coupled receptors Trends Biochem. Sci. 23 1998 418 422
46. G. Chen Constitutive receptor systems for drug discovery J. Pharmacol. Toxicol. Methods 42 1999 199 206
47. M.J. Millan Inverse agonists and serotonergic transmission: from recombinant, human serotonin (5-HT)1B receptors to G-protein coupling and function in corticolimbic structures in vivo Neuropsychopharmacology 21 1999 61S 67S
48. R.A. de Ligt Inverse agonism at G protein-coupled receptors: (patho)physiological relevance and implications for drug discovery Br. J. Pharmacol. 130 2000 1 12
49. C. Parnot Lessons from constitutively active mutants of G protein-coupled receptors Trends Endocrinol. Metab. 13 2002 336 343
50. R. Seifert, and K. Wenzel-Seifert Constitutive activity of G-protein-coupled receptors: cause of disease and common property of wild-type receptors Naunyn Schmiedebergs Arch. Pharmacol. 366 2002 381 416
51. P.G. Strange Mechanisms of inverse agonism at G-protein-coupled receptors Trends Pharmacol. Sci. 23 2002 89 95
52. G. Milligan Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective Mol. Pharmacol. 64 2003 1271 1276
53. R. Seifert, and T. Wieland G Protein-coupled Receptors as Drug Targets: Analysis of Activation and Constitutive Activity 2005 John Wiley & Sons
54. M. Birnbaumer Mutations and diseases of G protein coupled receptors J. Recept. Signal Transduct. Res. 15 1995 131 160
55. M.M. Rosenkilde Virally encoded 7TM receptors Oncogene 20 2001 1582 1593
56. M.J. Smit Virally encoded G protein-coupled receptors: targets for potentially innovative anti-viral drug development Curr. Drug Targets 4 2003 431 441
57. Y. Zou Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II Nat. Cell Biol. 6 2004 499 506
58. T. Kenakin Allosteric modulators: the new generation of receptor antagonist Mol. Interv. 4 2004 222 229
59. S. Morisset High constitutive activity of native H3 receptors regulates histamine neurons in brain Nature 408 2000 860 864
60. C.A. Milano Myocardial expression of a constitutively active alpha 1B-adrenergic receptor in transgenic mice induces cardiac hypertrophy Proc. Natl. Acad. Sci. U. S. A. 91 1994 10109 10113
61. E. Schipani Targeted expression of constitutively active receptors for parathyroid hormone and parathyroid hormone-related peptide delays endochondral bone formation and rescues mice that lack parathyroid hormone-related peptide Proc. Natl. Acad. Sci. U. S. A. 94 1997 13689 13694
62. B. Holst, and T.W. Schwartz Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation Trends Pharmacol. Sci. 25 2004 113 117
63. R.A. Adan, and M.J. Kas Inverse agonism gains weight Trends Pharmacol. Sci. 24 2003 315 321
64. D. Huszar Targeted disruption of the melanocortin-4 receptor results in obesity in mice Cell 88 1997 131 141
65. M.M. Ollmann Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein Science 278 1997 135 138
66. W.A. Nijenhuis AgRP(83-132) acts as an inverse agonist on the human-melanocortin-4 receptor Mol. Endocrinol. 15 2001 164 171
67. R.J. Lefkowitz G protein-coupled receptors. III. New roles for receptor kinases and beta-arrestins in receptor signaling and desensitization J. Biol. Chem. 273 1998 18677 18680
68. M. Azzi Beta-arrestin-mediated activation of MAPK by inverse agonists reveals distinct active conformations for G protein-coupled receptors Proc. Natl. Acad. Sci. U. S. A. 100 2003 11406 11411
69. N. Audet Internalization and Src activity regulate the time course of ERK activation by delta opioid receptor ligands J. Biol. Chem. 280 2005 7808 7816
70. J. Kim Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling Proc. Natl. Acad. Sci. U. S. A. 102 2005 1442 1447
71. X.R. Ren Different G protein-coupled receptor kinases govern G protein and beta-arrestin-mediated signaling of V2 vasopressin receptor Proc. Natl. Acad. Sci. U. S. A. 102 2005 1448 1453
72. A. Scheer Constitutively active mutants of the alpha 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation EMBO J. 15 1996 3566 3578
73. A. Scheer The activation process of the alpha1B-adrenergic receptor: potential role of protonation and hydrophobicity of a highly conserved aspartate Proc. Natl. Acad. Sci. U. S. A. 94 1997 808 813
74. P.J. Greasley Mutational and computational analysis of the alpha(1b)-adrenergic receptor. Involvement of basic and hydrophobic residues in receptor activation and G protein coupling J. Biol. Chem. 276 2001 46485 46494
75. P.J. Greasley Mutagenesis and modelling of the alpha(1b)-adrenergic receptor highlight the role of the helix 3/helix 6 interface in receptor activation Mol. Pharmacol. 61 2002 1025 1032
76. U. Gether Agonists induce conformational changes in transmembrane domains III and VI of the beta2 adrenoceptor EMBO J. 16 1997 6737 6747
77. J.A. Javitch Constitutive activation of the beta2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment J. Biol. Chem. 272 1997 18546 18549
78. S.G. Rasmussen Mutation of a highly conserved aspartic acid in the beta2 adrenergic receptor: constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6 Mol. Pharmacol. 56 1999 175 184
79. U. Gether Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility J. Biol. Chem. 272 1997 2587 2590
80. W.P. Spooren Novel allosteric antagonists shed light on mglu(5) receptors and CNS disorders Trends Pharmacol. Sci. 22 2001 331 337
81. M.L. Parmentier A model for the functioning of family 3 GPCRs Trends Pharmacol. Sci. 23 2002 268 274
82. P. Malherbe Mutational analysis and molecular modeling of the allosteric binding site of a novel, selective, noncompetitive antagonist of the metabotropic glutamate 1 receptor J. Biol. Chem. 278 2003 8340 8347
83. C. Goudet Heptahelical domain of metabotropic glutamate receptor 5 behaves like rhodopsin-like receptors Proc. Natl. Acad. Sci. U. S. A. 101 2004 378 383
84. T.A. Spalding Discovery of an ectopic activation site on the M(1) muscarinic receptor Mol. Pharmacol. 61 2002 1297 1302
85. M.T. Bianchi, and R.L. Macdonald Agonist Trapping by GABAA Receptor Channels J. Neurosci. 21 2001 9083 9091
86. C. Rogers Benzodiazepine and beta-carboline regulation of single GABAA receptor channels of mouse spinal neurones in culture J. Physiol. 475 1994 69 82
87. S. Ueno Bicuculline and gabazine are allosteric inhibitors of channel opening of the GABAA receptor J. Neurosci. 17 1997 625 634
88. S. Tucek, and J. Proska Allosteric modulation of muscarinic acetylcholine receptors Trends Pharmacol. Sci. 16 1995 205 212
89. W. Soudijn Allosteric modulation of G protein-coupled receptors: perspectives and recent developments Drug Discov. Today 9 2004 752 758
90. A. Christopoulos, and T. Kenakin G protein-coupled receptor allosterism and complexing Pharmacol. Rev. 54 2002 323 374